Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in its own shares conducted on July 9, 2025. The filing was submitted on July 10, 2025. The transaction was executed through Merrill Lynch International as part of the Company's existing share buyback programme, pursuant to a non-discretionary agreement entered into on June 4, 2025.
Key Financial Metrics
The filing details a specific share repurchase event rather than providing comprehensive financial statements. Key metrics for this transaction include:
- Shares Purchased: 473,780 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,403.50 GBp; highest price paid was 1,430.00 GBp.
- Average Price: Volume-weighted average price paid was 1,422.07 GBp.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON). No purchases were made on CBOE Europe venues (CHIX or BATE).
- Treasury Holdings: Following this purchase, GSK holds 229,552,795 ordinary shares in treasury.
- Shares in Issue: 4,085,829,055 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 5.62% of the total voting rights.
Material Changes
Since the commencement of the current buyback agreement on June 4, 2025, the Company has purchased a total of 11,418,412 ordinary shares. This specific filing represents the incremental purchase made on July 9, 2025, contributing to the reduction of shares in issue and the increase in treasury holdings.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, earnings outlook, or management commentary regarding future financial performance. It is a regulatory disclosure of a completed capital allocation activity. The filing confirms compliance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules (DTR 5.5.1R) regarding the notification of treasury share holdings.
Investor Verification Checklist
- Verify the total number of shares purchased under the current buyback programme (11,418,412 since June 4, 2025).
- Confirm the updated treasury share count (229,552,795) and its impact on the denominator for shareholder notification thresholds.
- Review the volume-weighted average price (1,422.07 GBp) against the prevailing market price on July 9, 2025.
- Note that the filing does not provide data on revenue, profit, cash flow, or debt levels; refer to the most recent Form 20-F or interim results for those metrics.